HERPES ZOSTER
Clinical trials for HERPES ZOSTER explained in plain language.
Never miss a new study
Get alerted when new HERPES ZOSTER trials appear
Sign up with your email to follow new studies for HERPES ZOSTER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Shingles vaccine study shows promise for rheumatoid arthritis patients
⭐️ VACCINE ⭐️ CompletedThis study looked at how safe and effective two shingles vaccines (Zostavax and Shingrix) are in people with rheumatoid arthritis who are taking the drug abatacept. About 154 adults took part, and researchers measured their immune response and any side effects. The goal was to se…
Matched conditions: HERPES ZOSTER
Phase: PHASE2 • Sponsor: Kevin Winthrop • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 12:29 UTC
-
New mRNA shingles shot shows promise in early trial
⭐️ VACCINE ⭐️ CompletedThis early-stage study tested a new mRNA vaccine called IN001 for preventing shingles in 150 healthy adults aged 50 to 69. The main goals were to check the vaccine's safety, side effects, and how well it triggers the immune system. Researchers gave different doses to find the bes…
Matched conditions: HERPES ZOSTER
Phase: PHASE1 • Sponsor: Shenzhen Shenxin Biotechnology Co., Ltd • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 12:02 UTC
-
Shingles vaccine stays effective for years, new study confirms
⭐️ VACCINE ⭐️ CompletedThis study followed over 7,500 older adults who received the shingles vaccine to see how well it prevents shingles over many years. Researchers also tested giving extra doses to some participants. The goal was to understand how long protection lasts and whether booster shots are …
Matched conditions: HERPES ZOSTER
Phase: PHASE3 • Sponsor: GlaxoSmithKline • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 08:03 UTC
-
Can a vaccine stop shingles from coming back? new study targets adults 50+
⭐️ VACCINE ⭐️ CompletedThis study tested a two-dose shingles vaccine (HZ/su) in 1,430 adults aged 50 and older who had already experienced shingles. The goal was to see if the vaccine could prevent the virus from coming back and to check its safety and immune response. Participants received either the …
Matched conditions: HERPES ZOSTER
Phase: PHASE3 • Sponsor: GlaxoSmithKline • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 08:01 UTC
-
Shingles nerve pain linked to higher dementia risk in massive study
Knowledge-focused CompletedThis study looked at health records of nearly 69,000 adults aged 40 and older to see if those who develop lasting nerve pain after shingles (postherpetic neuralgia) have a higher chance of getting dementia later. Researchers compared people with and without this nerve pain, match…
Matched conditions: HERPES ZOSTER
Sponsor: China Medical University Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:04 UTC
-
Shingles study aims to predict who gets lingering nerve pain
Knowledge-focused CompletedThis study looked at 151 adults with shingles to find clues that might predict who will develop lasting nerve pain (postherpetic neuralgia). Researchers collected blood samples and health information at the start and checked for pain three months later. The goal was to create a r…
Matched conditions: HERPES ZOSTER
Sponsor: First Affiliated Hospital of Zhejiang University • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:03 UTC